Wen Jun, Lau Harry Cheuk-Hay, Peppelenbosch Maikel, Yu Jun
State Key Laboratory of Digestive Disease, Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong.
Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Postbus 2040, 3000 CA Rotterdam, The Netherlands.
Biomedicines. 2021 Nov 12;9(11):1680. doi: 10.3390/biomedicines9111680.
Gastric cancer (GC) is one of the global leading causes of cancer death. The association between , which is a predominant risk factor for GC, with GC development has been well-studied. Recently, accumulating evidence has demonstrated the presence of a large population of microorganisms other than in the human stomach. Existing sequencing studies have revealed microbial compositional and functional alterations in patients with GC and highlighted a progressive shift in the gastric microbiota in gastric carcinogenesis with marked enrichments of oral or intestinal commensals. Moreover, using a combination of gastric bacterial signatures, GC patients could be significantly distinguished from patients with gastritis. These findings, therefore, emphasize the importance of a collective microbial community in gastric carcinogenesis. Here, we provide an overview of non- gastric microbes in gastric carcinogenesis. The molecular mechanisms of gastric microbes-related carcinogenesis and potential clinical applications of gastric microbiota as biomarkers of GC are also explored.
胃癌(GC)是全球癌症死亡的主要原因之一。幽门螺杆菌是胃癌的主要危险因素,其与胃癌发生之间的关联已得到充分研究。最近,越来越多的证据表明,人类胃部除幽门螺杆菌外还存在大量微生物。现有的测序研究揭示了胃癌患者微生物组成和功能的改变,并强调了胃癌发生过程中胃微生物群的渐进性变化,其中口腔或肠道共生菌显著富集。此外,利用胃部细菌特征的组合,可以将胃癌患者与胃炎患者显著区分开来。因此,这些发现强调了微生物群落整体在胃癌发生中的重要性。在这里,我们概述了胃癌发生过程中胃部非幽门螺杆菌微生物。还探讨了胃微生物相关致癌作用的分子机制以及胃微生物群作为胃癌生物标志物的潜在临床应用。